Daniel J Baillache

4PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 15, 2023
Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells.

Daniel J Baillache, Teresa Valero, Álvaro Lorente-Macías

|Jan 03, 2022
A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo.

Catherine Adam, Thomas L Bray, Ana M Pérez-López

|Oct 08, 2021
Small Molecule Kinase Inhibitor Drugs (1995-2021): Medical Indication, Pharmacology, and Synthesis.

Cecilia C Ayala-Aguilera, Teresa Valero, Álvaro Lorente-Macías

|Jan 22, 2021
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold.

Daniel J Baillache, Asier Unciti-Broceta

Pageof 1